January 12, 2018
Rose
Correction: A previous version of this story mistated the projected timeline for the combined product. It is Q1 this year, not Q1 next year. WellDoc and Voluntis, two companies with FDA-cleared, clinically validated platforms aimed at the management of Type 2 diabetes, have signed a commercial agreement to combine their technologies and offer joint products in the future.
from MobiHealthNews http://ift.tt/2AV4KNT
January 12, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Philips, Emory, Royal Perth use time zones, telehealth to provide nighttime care- Verily reported to be working on painless blood collection device
- Sharecare teams up with BCBS Minnesota, Walmart
- Apple Health Records: Where early adopters see the biggest impact so far
- PriorAuthNow bags $10.5M for automated prior authorization services
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment